Latest Syncom Formulations stock price

Syncom Formulations P/E Ratio

SYNCOMF • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
23.04
Moderate Valuation
High - Growth expectations or overvalued

Current Valuation Metrics

P/E Ratio 23.04
Current Price ₹13.13
EPS (TTM) ₹0.57
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 42.62
Historical Range 39.22 - 44.4
Percentile 0.0%

Sector Context

Sector Average 53.4
Sector Median 31.12
Sector Rank #11 of 132
Sector Percentile 8.3%

Earnings Breakdown (TTM)

TTM EPS ₹0.71
Sept 2025 ₹0.18
Mar 2025 ₹0.16

Key P/E Ratio Insights for Syncom Formulations

  • Current PE is 45.9% below historical average
  • Trading at discount to sector average PE of 53.4

View the SYNCOMF equity price for detailed stock performance.

P/E Ratio Historical Trend for Syncom Formulations

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 39.22 0.51 ₹20.00 BSE High
2023 44.24 0.34 ₹15.04 BSE High
2022 44.4 0.2 ₹8.88 BSE High

Sector P/E Ratio Comparison

Comparing Syncom Formulations with other companies in Healthcare sector
Sector Average
53.4
Sector Median
31.12
Lowest P/E
1.5
Highest P/E
628.04
Companies
132
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 1.5 ₹51 Low
Ind Swift Laboratories INDSWFTLAB 3.18 ₹733 Low
Murae Organisor MURAE 3.86 ₹55 Low
Fermenta Biotech FERMENTA 9.01 ₹1,010 Low
Zenith Drugs ZENITHDRUG 9.06 ₹84 Low
Galaxy Medicare GML 9.5 ₹32 Low
Balaxi Pharmaceuticals BALAXI 10.06 ₹139 Low
Natco Pharma NATCOPHARM 10.8 ₹17,006 Low
Vasundhara Rasayans VRL 11.3 ₹51 Low
Mohini Health & Hygiene MHHL 11.84 ₹69 Low